Inventor · disambiguated record
Holly Reichard
Also filed as: REICHARD HOLLY
24 granted patents·2 pending applications·68 citations·filing 2013–2024
95Inventor score
Files withTAKEDA PHARMACEUTICALS CO19ENVOY THERAPEUTICS INC2TAKEDA PHARMACEUTICAL2BROWN JASON W1HITCHCOCK STEPHEN1
Top patents by PatentIndex Score
26 records- 0192US9556130B24-oxo-3,4-dihydro-1,2,3-benzotriazine modulators of GPR139TAKEDA PHARMACEUTICALS CO·Filed 2015·Granted Jan 31, 2017·9 cites·18 claims
- 0291US11173161B24-oxo-3,4-dihydro-1,2,3-benzotriazine modulators of GPR139TAKEDA PHARMACEUTICALS CO·Filed 2020·Granted Nov 16, 2021·2 cites·33 claims
- 0391US10159677B24-OXO-3,4-dihydro-1,2,3-benzotriazine modulators of GPR139TAKEDA PHARMACEUTICALS CO·Filed 2017·Granted Dec 25, 2018·7 cites·32 claims
- 0490US9770450B24-OXO-3,4-dihydro-1,2,3-benzotriazine as modulators of GPR139TAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Sep 26, 2017·7 cites·32 claims
- 0588US9303045B25-HT3 receptor antagonistsTAKEDA PHARMACEUTICAL·Filed 2013·Granted Apr 5, 2016·7 cites·11 claims
- 0687US10561662B24-oxo-3,4-dihydro-1,2,3-benzotriazine modulators of GPR139TAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Feb 18, 2020·4 cites·32 claims
- 0787US9012447B25-HT3 receptor antagonistsENVOY THERAPEUTICS INC·Filed 2013·Granted Apr 21, 2015·8 cites·15 claims
- 0886US9346829B25-HT3 receptor antagonistsHITCHCOCK STEPHEN·Filed 2015·Granted May 24, 2016·5 cites·2 claims
- 0985US9670229B25-HT3 receptor antagonistsTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Jun 6, 2017·3 cites·11 claims
- 1084US9770452B2Quinoxaline derivatives as GPR6 modulatorsTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Sep 26, 2017·4 cites·22 claims
- 1180US9487526B2Quinoxaline derivatives as GPR6 modulatorsENVOY THERAPEUTICS INC·Filed 2013·Granted Nov 8, 2016·5 cites·21 claims
- 1277US10179783B2Tetrahydropyridopyrazines as modulators of GPR6TAKEDA PHARMACEUTICALS CO·Filed 2015·Granted Jan 15, 2019·2 cites·8 claims
- 1375US10077266B2Substituted pyrido[3,4-b]pyrazines as GPR6 modulatorsTAKEDA PHARMACEUTICALS CO·Filed 2017·Granted Sep 18, 2018·1 cites·11 claims
- 1471US9708313B2Substituted pyrido[3,4-b]pyrazines as GPR6 modulatorsBROWN JASON W·Filed 2015·Granted Jul 18, 2017·1 cites·15 claims
- 1570US9181249B2Substituted pyrido[3,4-b]pyrazines as GPR6 modulatorsTAKEDA PHARMACEUTICAL·Filed 2014·Granted Nov 10, 2015·1 cites·19 claims
- 1669US10738046B2Substituted pyrido[3,4-b]pyrazines as GPR6 modulatorsTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Aug 11, 2020·0 cites·21 claims
- 1768US10597392B2Tetrahydropyridopyrazines as modulators of GPR6TAKEDA PHARMACEUTICAL CORPORATION LTD·Filed 2018·Granted Mar 24, 2020·1 cites·11 claims
- 1868US10407443B25-HT3 receptor antagonistsTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Sep 10, 2019·0 cites·14 claims
- 1968US10000468B2Pyrazines as modulators of GPR6TAKEDA PHARMACEUTICALS CO·Filed 2015·Granted Jun 19, 2018·1 cites·10 claims
- 2065US10125145B25-HT3 receptor antagonistsTAKEDA PHARMACEUTICALS CO·Filed 2017·Granted Nov 13, 2018·0 cites·12 claims
- 2163US2024309016A1Macrocyclic heterocycle compounds and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2024·Application pending·0 cites
- 2263US2018072758A15ht3 receptor antagonistsTAKEDA PHARMACEUTICALS CO·Filed 2017·Application pending·0 cites
- 2362US9695195B25-HT3 receptor antagonistsTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Jul 4, 2017·0 cites·9 claims
- 2461US10406157B2Tetrahydropyridopyrazine modulators of GPR6TAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Sep 10, 2019·0 cites·28 claims
- 2551US10273225B2Pyrazines as modulators of GPR6TAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Apr 30, 2019·0 cites·12 claims
- 2649US12370192B2Azole-fused pyridazin-3(2H)-one derivativesTAKEDA PHARMACEUTICALS CO·Filed 2020·Granted Jul 29, 2025·0 cites·28 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →